Follow up and recurrence of colorectal cancer

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F12%3A%230000391" target="_blank" >RIV/00064190:_____/12:#0000391 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.5772/2443" target="_blank" >http://dx.doi.org/10.5772/2443</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5772/2443" target="_blank" >10.5772/2443</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Follow up and recurrence of colorectal cancer

Popis výsledku v původním jazyce

Despite optimal primary treatment, with adequate surgery with or without adjuvant chemotherapy, 30%?50% of patients with colon cancer will relapse and die of their disease. The principal aim of follow-up programmes after curative resection of colorectalcancer is to improve survival (Gan et al., 2007). To achieve this goal, patients are screened for early recurrent disease with the intent of a second curative surgery. Patients with a history of colorectal cancer are also at risk to develop new primary colorectal cancers (CRC). The risk of development of new primary lesions has been estimated to 0,35% per year (Cali et al.,1993). Bouvier et al reported the incidence of metachronous cancer as being 1.8% at five years, 3.4% at 10 years, and 7.2% at 20 years with the greatest excess risk between one and five years post-surgery(Bouvier et al. 2008).

Název v anglickém jazyce

Follow up and recurrence of colorectal cancer

Popis výsledku anglicky

Despite optimal primary treatment, with adequate surgery with or without adjuvant chemotherapy, 30%?50% of patients with colon cancer will relapse and die of their disease. The principal aim of follow-up programmes after curative resection of colorectalcancer is to improve survival (Gan et al., 2007). To achieve this goal, patients are screened for early recurrent disease with the intent of a second curative surgery. Patients with a history of colorectal cancer are also at risk to develop new primary colorectal cancers (CRC). The risk of development of new primary lesions has been estimated to 0,35% per year (Cali et al.,1993). Bouvier et al reported the incidence of metachronous cancer as being 1.8% at five years, 3.4% at 10 years, and 7.2% at 20 years with the greatest excess risk between one and five years post-surgery(Bouvier et al. 2008).

Druh

C - Kapitola v odborné knize

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Colorectal Cancer - From Prevention to Patient Care

ISBN

978-953-51-0028-7

Počet stran výsledku

15

Strana od-do

364-378

Počet stran knihy

538

Název nakladatele

InTech

Místo vydání

—

Kód UT WoS kapitoly

—